T1	p 64 115	group A beta-haemolytic streptococcal pharyngitis .
T2	p 196 249	beta-haemolytic streptococcal ( GABHS ) pharyngitis .
T3	p 386 405	GABHS pharyngitis .
T4	p 498 554	New Zealand . Children presenting with GABHS pharyngitis
T5	p 837 842	GABHS
T6	p 1230 1279	353 children with positive throat swabs for GABHS
T7	p 2035 2071	GABHS in children with pharyngitis .
T8	i 6 60	Once-daily amoxicillin versus twice-daily penicillin V
T9	i 228 233	GABHS
T10	i 304 325	QD ) oral amoxicillin
T11	i 363 382	) oral penicillin V
T12	i 386 391	GABHS
T13	i 404 405	.
T14	i 574 603	oral amoxicillin 1500 mg QD (
T15	i 617 627	bodyweight
T16	i 634 681	or=30 kg ) or to oral penicillin V 500 mg BID (
T17	i 685 688	250
T18	i 695 705	bodyweight
T19	i 710 722	< or=20 kg )
T20	i 727 774	10 days . Observed medication and weekend diary
T21	i 837 842	GABHS
T22	i 1161 1172	amoxicillin
T23	i 1177 1187	penicillin
T24	i 1299 1310	amoxicillin
T25	i 1326 1338	penicillin V
T26	i 1937 1953	oral amoxicillin
T27	i 1985 1995	penicillin
T28	i 2035 2040	GABHS
T29	o 746 780	medication and weekend diary cards
T30	o 802 844	adherence . OUTCOME Eradication of GABHS ,
T31	o 919 933	GABHS isolates
T32	o 964 1015	bacteriological treatment failures ( and relapses )
T33	o 1131 1153	success of eradication
T34	o 1248 1269	positive throat swabs
T35	o 1274 1279	GABHS
T36	o 1394 1411	positive cultures
T37	o 1516 1547	failures ( including relapses )
T38	o 1730 1752	resolution of symptoms
T39	o 1803 1840	unsubstantiated acute rheumatic fever
T40	o 2035 2040	GABHS